About the Journal

Brief Communications in Cardio-Renal-Metabolic Diseases is an online-only open-access, peer-reviewed medical journal committed to the rapid and responsible dissemination of concise scholarly work across the cardio-renal-metabolic disease spectrum. The journal is designed to support short-format scientific communication that is timely, clinically relevant, and accessible to a broad medical and public health audience.

Open Access Policy

The journal provides immediate open access to all published content. Readers are permitted to read, download, copy, distribute, and print articles without subscription or access fees. This journal operates under a Creative Commons Attribution–NonCommercial (CC BY-NC) license, allowing non-commercial use with appropriate citation of the original work.

Peer Review Process

All submissions undergo editorial screening followed by peer review. The journal follows a double-blind peer review process to ensure impartial evaluation of scientific quality, ethical standards, and relevance. Editorial decisions are based on methodological soundness, clarity, and contribution to clinical or public health practice.

Article Processing Charges

Brief Communications in Cardio-Renal-Metabolic Diseases does not charge any article processing fees (APCs), submission fees, or publication fees.

All costs associated with editorial management, peer review, and online publication are fully supported by mySugarClinic. Authors are not required to make any payment at any stage of the submission, review, or publication process.

Publishing Model

Brief Communications in Cardio-Renal-Metabolic Diseases follows a continuous publishing model, wherein articles are published online immediately after completion of peer review, editorial processing, and final acceptance, without waiting for issue compilation. A single volume is maintained annually, with articles added on a rolling basis and assigned unique article identifiers. This model ensures rapid dissemination of concise, high-impact research in cardio-renal-metabolic medicine.

Editorial Governance

The journal is led by an Editor-in-Chief and supported by a multidisciplinary Editorial Board comprising clinicians and researchers in cardiology, nephrology, diabetology, primary care, and public health. The Editorial Board is responsible for maintaining academic integrity, editorial independence, and timely decision-making.

Ethics and Publication Standards

The journal adheres to the recommendations of the International Committee of Medical Journal Editors (ICMJE) and follows the principles of the Committee on Publication Ethics (COPE). All research involving human participants must comply with ethical standards and institutional approval requirements. Authors are required to disclose conflicts of interest, funding sources, and ethical approvals where applicable.

Copyright and Licensing

Authors retain copyright of their work. By publishing in the journal, authors grant the journal the right of first publication under the applicable Creative Commons license. Proper attribution is required for any reuse of published material.

Ownership and Sponsorship

The journal is owned and published by mySugarClinic, an initiative of MSC Health Care Services LLP, and is endorsed by the Association for Social and Preventive Diabetology (ASPD). The journal does not receive direct commercial sponsorship that influences editorial decisions. All editorial processes are conducted independently.

Privacy Statement

Personal information collected during manuscript submission and peer review is used solely for editorial and publishing purposes. The journal does not share personal data with third parties beyond what is necessary for publication operations.

Archiving and Preservation

The journal ensures digital preservation of published content through regular backups and secure server infrastructure. All published articles remain permanently accessible on the journal website. The journal plans to participate in recognized digital archiving initiatives as it grows.